6/30/2020 8:37:21 AM
Vertex Announces Expansion Of Reimbursement Agreement With NHS England For Vertex's Cystic Fibrosis Medicines
6/26/2020 8:19:09 AM
Vertex :CHMP Grants Positive Opinion For KAFTRIO-KALYDECO In People Ages 12 & Older WithCystic Fibrosis With Genotypes
6/25/2020 9:21:37 AM
Vertex And Vertex Foundation Commit $4 Mln To Support Racial Equity And Social Justice
6/10/2020 3:02:42 AM
Vertex Says European Commission Has Granted Approval Of Label Extension For KALYDECO
6/3/2020 10:04:16 AM
Vertex Appoints Diana McKenzie To Board
5/1/2020 3:05:47 AM
Vertex Gets European CHMP Positive Opinion For KALYDECO For
Children And Adolescents With Cystic Fibrosis
4/29/2020 4:24:00 PM
Vertex Pharmaceuticals Inc. (VRTX) Has Raised Its 2020 Revenue Estimate To $5.3 Bln - $5.6 Bln From $5.1 Bln - $5.3 Bln
4/29/2020 4:05:35 PM
Vertex Pharma Q1 EPS $2.29 Vs. $1.03 Year Ago
4/27/2020 8:34:23 AM
Vertex Pharma, Affinia Therapeutics Establish Collaboration To Develop Novel AAV Capsids For Genetic Therapies
4/21/2020 2:12:38 AM
Vertex Enters Reimbursement Agreement In Switzerland For
ORKAMBI And SYMDEKO
3/27/2020 8:03:04 AM
Vertex Confirms 2020 Business Outlook
3/9/2020 9:56:54 AM
Vertex Pharma Says Global Coronavirus Outbreak No Impact On Its Supply Chain Or Its 2020 Business Outlook
2/25/2020 5:06:37 PM
Vertex: KALYDECO To Be Available To Eligible Patients With Cystic Fibrosis In New Zealand From March 1